157 related articles for article (PubMed ID: 32609843)
21. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
Zou YS; Hoppman NL; Singh ZN; Sawhney S; Kotiah SD; Baer MR
Cancer Genet; 2017 Apr; 212-213():38-44. PubMed ID: 28449810
[TBL] [Abstract][Full Text] [Related]
22. Solitary orbital involvement with juvenile xanthogranuloma.
Shields CL; Shields JA; Buchanon HW
Arch Ophthalmol; 1990 Nov; 108(11):1587-9. PubMed ID: 2123087
[TBL] [Abstract][Full Text] [Related]
23. Juvenile xanthogranuloma of the iris in an adult.
Parmley VC; George DP; Fannin LA
Arch Ophthalmol; 1998 Mar; 116(3):377-9. PubMed ID: 9514494
[TBL] [Abstract][Full Text] [Related]
24. PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
Arts FA; Sciot R; Brichard B; Renard M; de Rocca Serra A; Dachy G; Noël LA; Velghe AI; Galant C; Debiec-Rychter M; Van Damme A; Vikkula M; Helaers R; Limaye N; Poirel HA; Demoulin JB
Hum Mol Genet; 2017 May; 26(10):1801-1810. PubMed ID: 28334876
[TBL] [Abstract][Full Text] [Related]
25. Disseminated juvenile xanthogranuloma associated with follicular lymphoma in an adult: successful treatment with chemotherapy and rituximab. A review of the literature.
Narváez-Moreno B; Pulpillo-Ruiz Á; De Zulueta-Dorado T; Conejo-Mir J
Actas Dermosifiliogr; 2013 Apr; 104(3):242-6. PubMed ID: 22681714
[TBL] [Abstract][Full Text] [Related]
26. Bilateral retinal involvement in juvenile xanthogranuloma-Successful treatment with clofarabine.
Mifsud M; Picton S; Ainsworth J
Pediatr Blood Cancer; 2021 Nov; 68(11):e29222. PubMed ID: 34245213
[No Abstract] [Full Text] [Related]
27. Juvenile xanthogranuloma treated with local steroids.
Clements DB
Br J Ophthalmol; 1966 Nov; 50(11):663-5. PubMed ID: 4959023
[No Abstract] [Full Text] [Related]
28. [Application of reverse transcription-multiplex nested PCR to detect PDGFRB gene rearrangement in myeloproliferative disorders].
Zhou MH; Jiang MM; Gao L; Xu YY; Ding Y; Wang LL; Jing Y; Wang QS; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1443-6. PubMed ID: 22169300
[TBL] [Abstract][Full Text] [Related]
29. Juvenile xanthogranuloma masquerading as melanoma.
Fontanilla FA; Edward DP; Wong M; Tessler HH; Eagle RC; Goldstein DA
J AAPOS; 2009 Oct; 13(5):515-8. PubMed ID: 19840735
[TBL] [Abstract][Full Text] [Related]
30. Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene.
Yamazaki M; Nakaseko C; Takeuchi M; Ozawa S; Ishizuka Y; Hatanaka Y; Oshima-Hasegawa N; Muto T; Tsukamoto S; Mitsukawa S; Ohwada C; Takeda Y; Mimura N; Iseki T; Fukazawa M; Sakaida E
Intern Med; 2019 Dec; 58(23):3449-3453. PubMed ID: 31327842
[TBL] [Abstract][Full Text] [Related]
31. EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.
Schwab C; Ryan SL; Chilton L; Elliott A; Murray J; Richardson S; Wragg C; Moppett J; Cummins M; Tunstall O; Parker CA; Saha V; Goulden N; Vora A; Moorman AV; Harrison CJ
Blood; 2016 May; 127(18):2214-8. PubMed ID: 26872634
[TBL] [Abstract][Full Text] [Related]
32. Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.
Cain JA; Xiang Z; O'Neal J; Kreisel F; Colson A; Luo H; Hennighausen L; Tomasson MH
Blood; 2007 May; 109(9):3906-14. PubMed ID: 17218386
[TBL] [Abstract][Full Text] [Related]
33. Corneal juvenile xanthogranuloma in a 4-month-old child.
Ashmore ED; Wilson MW; Morris WR; Hill DA; Rodriguez-Galindo C; Haik BG
Arch Ophthalmol; 2003 Jan; 121(1):117-8. PubMed ID: 12523896
[No Abstract] [Full Text] [Related]
34. Kosaki overgrowth syndrome: A newly identified entity caused by pathogenic variants in platelet-derived growth factor receptor-beta.
Takenouchi T; Okuno H; Kosaki K
Am J Med Genet C Semin Med Genet; 2019 Dec; 181(4):650-657. PubMed ID: 31710779
[TBL] [Abstract][Full Text] [Related]
35. Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma.
Tsao AS; Lin H; Carter BW; Lee JJ; Rice D; Vaporcyan A; Swisher S; Mehran R; Heymach J; Nilsson M; Fan Y; Nunez M; Diao L; Wang J; Fujimoto J; Wistuba II; Hong WK
J Thorac Oncol; 2018 Feb; 13(2):246-257. PubMed ID: 29313814
[TBL] [Abstract][Full Text] [Related]
36. Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders.
Gallagher G; Horsman DE; Tsang P; Forrest DL
Cancer Genet Cytogenet; 2008 Feb; 181(1):46-51. PubMed ID: 18262053
[TBL] [Abstract][Full Text] [Related]
37. Fluorescein angiography of iris juvenile xanthogranuloma.
Danzig CJ; Shields CL; Mashayekhi A; Ehya H; Manquez ME; Shields JA
J Pediatr Ophthalmol Strabismus; 2008; 45(2):110-2. PubMed ID: 18404959
[TBL] [Abstract][Full Text] [Related]
38. Successful therapy of systemic xanthogranuloma in a child.
Unuvar E; Devecioglu O; Akcay A; Gulluoglu M; Uysal V; Oguz F; Sidal M
J Pediatr Hematol Oncol; 2007 Jun; 29(6):425-7. PubMed ID: 17551409
[TBL] [Abstract][Full Text] [Related]
39. Central nervous system juvenile xanthogranuloma after langerhans cell histiocytosis.
Abla O; Halliday W; Laughlin S; Weitzman S
Pediatr Blood Cancer; 2013 Feb; 60(2):342-3. PubMed ID: 23109301
[No Abstract] [Full Text] [Related]
40. Subconjunctival steroid in the management of uveal juvenile xanthogranuloma: a case report.
Treacy KW; Letson RD; Summers CG
J Pediatr Ophthalmol Strabismus; 1990; 27(3):126-8. PubMed ID: 2114475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
